Deep Tech Startups

NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions. Its lead candidate, ignaseclant (NMD670), is in clinical development for Charcot-Marie-Tooth disease, generalized myasthenia gravis, and spinal muscular atrophy.</parameter> <parameter name="founders">[]

3 investors

NOA develops wireless charging infrastructure for autonomous drones, robots, and industrial platforms, enabling contactless power transfer across air gaps without physical connectors or alignment requirements. The technology reduces maintenance, eliminates operator involvement in charging cycles, and maintains sealed enclosures for harsh field environments.

3 investors

NODAR develops stereo-vision technology that uses patented algorithms with standard cameras to produce long-range, high-precision 3D spatial data. It serves automotive and industrial applications, including passenger vehicles, autonomous trains, and monitoring and surveillance systems that rely on 3D data for autonomous machines.

3 investors

NodeShift is a technology company operating in the private AI space, with a globally distributed team. It was founded by former Cisco colleagues and has a presence in the USA and UAE.

3 investors

Nodle operates a decentralized physical infrastructure network (DePIN) that uses smartphones and BLE (Bluetooth Low Energy) to provide crowdsourced location and tracking services. Its network is used by enterprises for asset and vehicle tracking, such as tracking vehicles for recovery in France.

3 investors

Sabi is developing a thought-to-text wearable, a beanie with custom neuroimaging sensors that wirelessly reads brain signals to interpret what the wearer thinks or attempts to speak. The company builds custom ASIC-powered sensors and a Brain Foundation Model to map neural activity to thoughts, enabling AI agents to act on user intent.

3 investors

Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.

3 investors

Novamera develops a Surgical Mining technology platform that integrates with conventional drilling equipment to enable targeted extraction of narrow vein mineral deposits with reduced environmental impact. The company serves small-footprint mining operations seeking economically viable alternatives to conventional mining methods for low-grade or complex deposits.

3 investors

Novineer develops CAD design software that performs stiffness- and strength-based topology optimization using anisotropic material properties and the Tsai-Wu failure criteria. Its tools integrate geometry design with toolpath generation for manufacturability and run on cloud high-performance computing for parallel design and simulation.

3 investors

NPco builds AI-powered simulation software for industrial engineering and design, using foundational models that can start from as few as 25 high-fidelity samples to compress simulation cycles from months to days. It serves engineers and product makers in aerospace, defense, and energy industries.

3 investors

nT-Tao develops compact 20 MWe fusion systems, marketed as Tao Energy Boxes, designed to provide distributed, 24/7 firm on-site power on or off the grid. It targets energy-intensive infrastructure such as datacenters and AI power, maritime and ports, national and critical infrastructure, and EV fleet charging.

3 investors

Nuage Therapeutics develops drug discovery technologies for disordered proteins, focusing on precision treatments for aggressive cancers with limited therapeutic options. The company targets disease-causing protein targets rooted in human biology.

3 investors

Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.

3 investors

Nuclera provides multiplex protein screening technology for life science researchers, enabling faster access to and testing of proteins for drug discovery and development. The company serves protein scientists and research teams accelerating breakthroughs in structural biology and functional studies.

3 investors

Nulixir appears to be a beverage or wellness product company that formulates drinks with herbal extracts, amino acids, and vitamins. The page shows a board of advisors section featuring Gerry, an experienced executive with extensive background in consumer products, manufacturing, and beverage industry turnarounds.

3 investors

Numab develops multispecific antibody-based therapeutics using its proprietary λ-Cap and MATCH discovery and engineering platforms, aiming to improve on first-generation antibody therapies in potency, stability, effect duration, and safety. It maintains its own drug pipeline targeting clinically validated pathways and works with pharma and biotech partners on discovery and development.

3 investors

NuNet is a peer-to-peer protocol that discovers, matches, and settles compute workloads across distributed infrastructure including GPUs, CPUs, servers, edge devices, and data centers. It uses the NTX token for peer-to-peer settlement on Ethereum and Cardano, serving AI, robotics, energy, and data-center use cases with self-orchestrating decentralized compute.

3 investors

Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.

3 investors

Twindo converts iPhone/iPad scans, floor plans, and point clouds into accurate, editable CAD and BIM files for architectural and construction professionals. The platform uses LiDAR and proprietary 3D scanning technology to digitize physical spaces for design and building workflows.

3 investors

OMTX develops machine learning tools and datasets for drug discovery, helping researchers globally identify new therapeutic mechanisms of action and accelerate the development of medicines.

3 investors

OmniSpeech develops speech technology based on research into the physiology of human speech, with applications in audio, automotive, and consumer electronics. The company originated from research at the University of Maryland's Speech Communication Lab.

3 investors

OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

3 investors

OnePot is a tool for synthesizing molecules, with end-to-end encryption of users' molecular structures. It appears aimed at chemistry and drug discovery users who require confidentiality of their chemical data.

3 investors

Oosto develops computer vision AI that provides face, body, and action recognition algorithms to help organizations protect people, premises, and profits. Its technology emphasizes privacy-enhancing features, accuracy, and reduced bias for security-related applications.

3 investors